Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > LifeSci Communications

<< Previous

Bullboard Posts

Next >>

Comment by MoneyMouthon May 17, 2022 12:18pm

104 Views

Post# 34689455

RE:RE:RE:RE:LifeSci Communications

Ha, that just goes to show how narrow minded you are, summing todays news as "basically a private placement." $1.57 sets the base now, and the market will pay more based on the upside potential of the partnership. It's not going to be a straight up spike, and thank god for that. With a TSX uplisting and new money coming in from insitutions, we should find a new trading range within the next couple of months. I'm just happing that our days of $1.40 should be behind us now. Can we atleast all agree on that?

<< Previous

Bullboard Posts

Next >>

Golden Minerals closes Yoquivo gold-silver project sale